drugset / Trial / NCT03270553
A Study to Assess the Effect of Plazomicin on the Pharmacokinetics of Metformin
RandomizedCrossoverOpen-labelTreatment
Summary
This is a single-center, Phase 1, open label, randomized, two-sequence, two-period, crossover study to evaluate the drug-drug interaction potential between plazomicin and metformin in healthy subjects.
Timeline
- Start
- 2017-08-31
- Primary completion
- 2017-10-07
- Completion
- 2017-10-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metformin | Small molecule | 850 mg | Oral |
| Subject | plazomicin | Small molecule | 15 mg/kg | Intravenous |
Indications
No indication recorded.